Adapting to Industry Rebound: The Next Phase of Clinical Trials

Moving Medicine Forward · Jun 3, 2026 · 28m

What does a recovering clinical research market actually look like in 2026?

In this episode, Joel White, Owner of Market Cap Consulting, and Ryan Gifford, Vice President, Global Laboratory Services, Business Development & Client Management at CTI, join us to unpack the state of the industry—from the rebound in biotech funding to the growing importance of execution, site relationships, and smarter trial design.

We explore how increasing complexity is shaping partnerships, how labs and decentralized models are evolving, and what it will take to keep trials on track. Looking ahead, the…